Wezenla
Analogs of Wezenla
Find cheaper analogs and generic equivalents for Wezenla.
Active Ingredient: ustekinumab
Product Overview
About Wezenla
Wezenla is a prescription medicine that should be given under the supervision of a doctor who has experience in diagnosing and treating the diseases that Wezenla is used for.
What it is used for
Wezenla is used for plaque psoriasis, psoriatic arthritis, and Crohn’s disease.
How it is used
Wezenla is injected under the skin. The first injection is followed by another injection 4 weeks later. After that, one injection is given every 12 weeks. In Crohn’s disease, treatment is started Wezenla as an infusion (drip) into a vein lasting at least 1 hour. Eight weeks after the first infusion, Wezenla is given as an injection under the skin. Patients then continue with Wezenla injected under the skin every 8 or 12 weeks depending on how well the treatment is working. Patients or their caregivers may inject Wezenla once they have been trained, if their doctor thinks that this is appropriate.
How it works
The active substance in Wezenla, ustekinumab, is a monoclonal antibody, a type of protein that has been designed to recognise and attach to a specific target in the body. Ustekinumab attaches to 2 messenger molecules in the immune system called interleukin 12 and interleukin 23. Both are involved in inflammation and other processes that are important in psoriasis, psoriatic arthritis and Crohn’s disease. By blocking their activity, ustekinumab reduces the activity of the immune system and the symptoms of the disease.
Active substance: ustekinumab
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
